(Q57482613)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625722%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

EANM procedure guidelines for therapy of benign thyroid disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625722%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author

Daria Handkiewicz-Junak

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625722%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Michael Lassmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625722%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Markus Dietlein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625722%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Markus Luster

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625722%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Marcel P M Stokkel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625722%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

13 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625722%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625722%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625722%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625722%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

2218-2228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625722%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-010-1536-8

7 February 2020

exact match

0 references

cites work

Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-010-1536-8

A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter

21 January 2018

1 reference

12 December 2020

Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis

1 reference

12 December 2020

Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism.

1 reference

12 December 2020

A randomized controlled trial to evaluate the adjuvant effect of lithium on radioiodine treatment of hyperthyroidism

1 reference

12 December 2020

State of the art in nuclear medicine dose assessment

1 reference

12 December 2020

[Results of a risk adapted and functional radioiodine therapy in Graves' disease]

1 reference

12 December 2020

Guideline on radiation protection in medicine requires documentation of radioiodine therapy and follow-up: What are the benefits of an electronic database?

1 reference

12 December 2020

Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial

1 reference

12 December 2020

Radioiodine therapy and thyrostatic drugs and iodine

1 reference

12 December 2020

Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?

1 reference

12 December 2020

Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial

1 reference

12 December 2020

Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome

1 reference

12 December 2020

A Randomized Comparison of Radioiodine Doses in Graves’ Hyperthyroidism

1 reference

12 December 2020

[Evaluation of radioiodine therapy with fixed doses of 10 and 15 mCi in patients with Graves' disease]

1 reference

12 December 2020

[Guideline for radioiodine therapy for benign thyroid diseases (version 4)]

1 reference

12 December 2020

Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism

1 reference

12 December 2020

Radioiodine treatment for benign thyroid diseases.

1 reference

12 December 2020

Radioiodine therapy of thyroid autonomy

1 reference

12 December 2020

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

12 December 2020

Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy

1 reference

12 December 2020

Amiodarone and thyroid

1 reference

12 December 2020

Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy

1 reference

12 December 2020

Risk of thyroid cancer after exposure to 131I in childhood

1 reference

12 December 2020

Glucocorticoids do not influence the effect of radioiodine therapy in Graves' disease

1 reference

12 December 2020

Radioiodine therapy for thyroid volume reduction of large goitres

1 reference

12 December 2020

Outcome of radioiodine therapy without, on or 3 days off carbimazole: a prospective interventional three-group comparison

1 reference

12 December 2020

Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake

1 reference

12 December 2020

The use of radioiodine in the management of benign thyroid disease

1 reference

12 December 2020

Radiation exposure to family members of patients with thyrotoxicosis treated with iodine-131

1 reference

12 December 2020

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.

1 reference

12 December 2020

Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?

1 reference

12 December 2020

[Procedure guideline for radioiodine test (Version 3)]

1 reference

12 December 2020

Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group

1 reference

12 December 2020

Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients

1 reference

12 December 2020

Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.

1 reference

12 December 2020

Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism

1 reference

12 December 2020

Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study.

1 reference

12 December 2020

Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study.

1 reference

12 December 2020

Thyroid cancer risk after thyroid examination with 131I: a population-based cohort study in Sweden

1 reference

12 December 2020

Release of patients after therapy with unsealed radionuclides

1 reference

12 December 2020

Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment

1 reference

12 December 2020

An optimal treatment for pediatric Graves' disease is radioiodine.

1 reference

12 December 2020

[Volumetric analysis of thyroid lobes by real-time ultrasound (author's transl)]

1 reference

12 December 2020

The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial

1 reference

12 December 2020

Radiation-induced thyroid cancer--what's new?

1 reference

12 December 2020

Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter

1 reference

12 December 2020

Predictors of early remission of hyperthyroidism in children

1 reference

12 December 2020

Influence of iodine-131 dose on the outcome of hyperthyroidism in children

1 reference

12 December 2020

[Results of TcTUs-optimized radioiodine therapy in multifocal and disseminated autonomy]

1 reference

12 December 2020

Long-term risks in hyperthyroid patients treated with radioiodine: is there anything new?

1 reference

12 December 2020

Mortality in patients treated for hyperthyroidism with iodine-131.

1 reference

12 December 2020

Change in the intrathyroidal kinetics of radioiodine under continued and discontinued antithyroid medication in Graves' disease

1 reference

12 December 2020

Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?

1 reference

12 December 2020

Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules

1 reference

12 December 2020

A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients

1 reference

12 December 2020

The management of subclinical hyperthyroidism by thyroid specialists

1 reference

12 December 2020

Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?

1 reference

12 December 2020

Radioiodine therapy of euthyroid multinodular goitres

1 reference

12 December 2020

Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease

1 reference

12 December 2020

Propylthiouracil before 131I therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial

1 reference

12 December 2020

Radioiodine treatment for pediatric hyperthyroid Grave's disease

1 reference

12 December 2020

Multidetector computed tomography in the preoperative evaluation of retrosternal goiters: a useful procedure for patients for whom magnetic resonance imaging is contraindicated.

1 reference

12 December 2020

Radioactivity and thyroid cancer.

1 reference

12 December 2020

Comparison of two fixed activities of radioiodine therapy (370 vs. 555 MBq) in patients with Graves' disease

1 reference

12 December 2020

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study

1 reference

12 December 2020

Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres

1 reference

12 December 2020

Management of simple nodular goiter: current status and future perspectives

1 reference

12 December 2020

Therapeutic options in the management of toxic and nontoxic nodular goiter

1 reference

12 December 2020

Late consequences of radioiodine for diagnosis and therapy in Sweden

1 reference

12 December 2020

Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy?

1 reference

12 December 2020

Two-day thionamide withdrawal prior to radioiodine uptake sufficiently increases uptake and does not exacerbate hyperthyroidism compared to 7-day withdrawal in Graves' disease

1 reference

12 December 2020

Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease

1 reference

12 December 2020

Early treatment with low fixed dose (5 mCi) radioiodine therapy is effective in Indian subjects with Graves' disease

1 reference

12 December 2020

Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma

1 reference

12 December 2020

A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment

1 reference

12 December 2020

10.1007/S00259-010-1536-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20625722%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference